- People
- Offices
- Capabilities
back- Capabilities
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Emerging Companies and Venture Capital
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Fund Finance
- Global Human Capital and Compliance
- Investment Funds and Asset Management
- Leveraged Finance
- Mergers and Acquisitions (M&A)
- Middle East and Islamic Finance and Investment
- Private Equity
- Public Companies
- Real Estate
- Structured Finance and Securitization
- Tax
- Technology Transactions
- Government Matters
- back
- Government Matters
- Overview
- Antitrust
- Data, Privacy and Security
- Environmental, Health and Safety
- FDA and Life Sciences
- Government Advocacy and Public Policy
- Government Contracts
- Healthcare
- Innovation Protection
- International Trade
- National Security and Corporate Espionage
- Securities Enforcement and Regulation
- Special Matters and Government Investigations
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Antitrust
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Construction and Engineering Disputes
- Corporate and Securities Litigation
- E-Discovery
- Innovation Protection
- Intellectual Property
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries / Issues
- back
- Industries / Issues
- Automotive, Transportation and Mobility
- Energy Transition
- Energy
- Financial Services
- Food and Beverage
- Higher Education
- Life Sciences and Healthcare
- Technology
- Artificial Intelligence (AI) and Machine Learning
- Buy American
- Crisis Management
- Doing Business in Latin America
- Environmental Agenda
- Environmental, Social and Governance (ESG)
- Focus on Women's Health
- Russia/Ukraine
- Special Purpose Acquisition Companies (SPACs)
- Careers
- News & Insights
- About
- Languages
Pharmaceutical and Medical Device
Events 49 results
Conference
September 4, 2025
18th Annual King & Spalding Medical Device Summit
Webinar
May 22, 2025
Navigating U.S. Tariffs
Webinar
April 10, 2025
Combination, Personalized, and Advanced Therapy Medicinal Products
Webinar
March 20, 2025
Regulatory Exclusivities
Webinar
February 20, 2025
Orphan and Pediatric Medicinal Products
Webinar
January 22, 2025
Year in Review for Drug and Device Advertising and Promotion
Webinar
January 16, 2025
Steps Before Marketing Authorization (MA)
Speaking Engagement
December 13, 2024
Ulf Grundmann to Speak at Frankfurt School of Finance and Management’s International Healthcare Management MBA program
Webinar
December 4, 2024
Fundamentals of EU Pharmaceutical Law
Conference
November 12, 2024
Pharmaceutical University 2024
Webinar
October 24, 2024
Real-World Data for Clinical Trials: Brand New FDA Expectations for Use of Real-World Evidence for Regulatory Decision-Making
Speaking Engagement
October 16, 2024
Gillian Russell to Speak at FDLI’s Introduction to Advertising and Promotion for Medical Products Conference